FDAHealthJanuary 29, 2025
Glenmark Pharmaceuticals Inc., USA — Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-267-30.
⚠️ CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- January 29, 2025
Nationwide within the U.S
What's affected?
- Product
- Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-267-30.
- Brand
- ATOMOXETINE
- UPC
- 0368462265307
- Lot code
- 19233792
Additional details
Lot Numbers: 19233792, Exp.: 8/2025; 19233795, Exp.: 8/2025; 19234258, Exp.: 9/2025; 19240912, Exp.: 2/2026; 19241476, 19241477, Exp.: 3/2026; 19242599, Exp.: 6/2026; 19243163, 19243162, Exp.:7/2026;19243884, 19243887, Exp.:9/2026.
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 175,920 bottles.
Get Health recall alerts
Delivered to your inbox. Free. No account required.